W. Baiker

Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.

C. Pepine, W. Frishman, R. Weiss, 1995, Journal of the American College of Cardiology.

Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris☆

S. Glasser, U. Thadani, W. Baiker, 1997 .

Efficacy and duration of action of three doses of Zatebradine (ULFS 49 CL) in patients with chronic angina pectoris compared to placebo

W. Baiker, G. Nehmiz, M. Keck, 1991 .

Long-term efficacy and safety of Pimobendan in moderate heart failure: A double-blind parallel 6-month comparison with enalapril

G. Baumann, W. Remme, W. Baiker, 1994 .